• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The International journal of pharmacy practice >Using the BVIRC Framework for Complex Interventions to identify and develop strategies to promote the evidence-based supply of non-prescription medicines
【24h】

Using the BVIRC Framework for Complex Interventions to identify and develop strategies to promote the evidence-based supply of non-prescription medicines

机译：使用BVIRC复​​杂干预框架来确定和制定策略以促进循证非处方药的供应

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Many governments are promoting the greater availability of medicines to the public to reduce national drug expenditure In the UK, the reclassifi-cation of medicines from prescription only (POM) to pharmacy (P) or general sales list (GSL) status has provided the public with greater direct access to a growing range of medicines. Medicines with P and GSL status (also known as non-prescription medicines) are sold from community pharmacies either by, or under the supervision of, a pharmacist. There is evidence that non-prescription medicines are sometimes supplied or used inappropriately Further more, drugs that have been reclassified recently tend to be more potent than those reclassified in earlier years, thus their inappropriate supply and use may have even greater implications for patient safety.The Medical Research Council's (MRC) Framework for Complex Interventions comprises five components: theory, modelling, exploratory trial(s), definitive randomised controlled trial (RCT) and long-term implementation, This framework was used to identify and develop evidence-based strategies to promote the evidence-based supply of non-prescription medicines (NPMs) from community pharmacies.
机译：许多政府都在促进向公众提供更多药品以减少国家药品支出。在英国，药品从仅处方（POM）到药店（P）或一般销售清单（GSL）的重新分类为公众提供了可以直接获得越来越多的药品。具有P和GSL身份的药品（也称为非处方药）是由药剂师或在药剂师的监督下从社区药房出售的。有证据表明，有时非处方药的供应或使用不当。此外，最近重新分类的药物比早年重新分类的药物更有效，因此，不适当的供应和使用可能对患者安全产生更大的影响。医学研究理事会（MRC）的复杂干预框架包括五个部分：理论，建模，探索性试验，确定性随机对照试验（RCT）和长期实施，该框架用于识别和制定基于证据的策略促进社区药店提供基于证据的非处方药（NPM）供应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号